Monitoring tumor recurrence with nasopharyngeal swab and latent membrane protein-1 and Epstein-Barr nuclear antigen-1 gene detection in treated patients with nasopharyngeal carcinoma

Laryngoscope

Volumn 114, Issue 11 I, 2004, Pages 2027-2030

  Hao, Sheng Po ^a,b   Tsang, Ngan Ming ^a   Chang, Kai Ping ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b NONE   (Taiwan)

Author keywords

Epstein Barr virus; Gene; Latent membrane protein 1; Local recurrence; Nasopharyngeal carcinoma

Indexed keywords

EPSTEIN BARR VIRUS ANTIGEN; EPSTEIN BARR VIRUS NUCLEAR ANTIGEN 1; LATENT MEMBRANE PROTEIN 1; UNCLASSIFIED DRUG; VIRUS DNA;

ARTICLE; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; EAR NOSE THROAT SURGERY; EPSTEIN BARR VIRUS; GENE IDENTIFICATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; NASOPHARYNGECTOMY; NASOPHARYNX; NASOPHARYNX CARCINOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RELIABILITY; SENSITIVITY AND SPECIFICITY; VIRUS GENE; VIRUS GENOME;

DNA, VIRAL; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; FOLLOW-UP STUDIES; HUMANS; NASOPHARYNGEAL NEOPLASMS; NEOPLASM RECURRENCE, LOCAL; PROSPECTIVE STUDIES; VIRAL MATRIX PROTEINS;

EID: 9144246314     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mlg.0000147941.75002.d4     Document Type: Article

References (12)

1. Cheng SH, Liu TW, Jian JJ, et al. Concomitant chemotherapy and radiotherapy for locally advanced nasopharyngeal carcinoma. Cancer J Sci Am 1997;3:100-106.
2. Hao SP, Tsang NM, Chang CN. Salvage surgery for recurrent nasopharyngeal carcinoma. Arch Otolaryngol Head Neck Surg 2002;128:63-67.
3. Cohen JI. Epstein-Barr virus infection. N Engl J Med 2000; 343:481-492.
4. Lin SY, Tsang NM, Kao SC, et al. Presence of Epstein-Barr virus latent membrane protein 1 gene in the nasopharyngeal swabs from patients with nasopharyngeal carcinoma. Head Neck 2001;23:194-200.
5. Chang KP, Hao SP, Lin SY, et al. A lack of association between p53 mutations and recurrent nasopharyngeal carcinomas refractory to radiotherapy. Laryngoscope 2002; 112:2015-2019.
6. Jeng KC, Hsu CY, Liu MT, et al. Prevalence of Taiwan variant of Epstein-Barr virus in throat washings from patients with head and neck tumors in Taiwan. J Clin Microbiol 1994;32:28-31.
7. Baichwal VR, Sugden B. The multiple membrane-spanning segments of the BNLF-1 oncogene from Epstein-Barr virus are required for transformation. Oncogene 1989;4:67-74.
8. Hao SP, Tsang NM, Chang KP. Screening nasopharyngeal carcinoma by detection of the latent membrane protein 1 (LMP-1) gene with nasopharyngeal swabs. Cancer 2003;97: 1909-1913.
9. Hao SP, Tsang NM, Chang KP. Differentiation of recurrent nasopharyngeal carcinoma and skull base osteoradionecrosis by Epstein-Barr virus-derived latent membrane protein-1 gene. Laryngoscope 2001;111:650-652.
10. Waldron J, Van Hasselt CA, Wong KY. Sensitivity of biopsy using local anesthesia in detecting nasopharyngeal carcinoma. Head Neck 1992;14:24-27.
11. Wei WI, Sham JS, Zong YS, et al. The efficacy of fiberoptic endoscopic examination and biopsy in the detection of early nasopharyngeal carcinoma. Cancer 1991;67:3127-3130.
12. Tsang NM, Chuang CC, Tseng CK, et al. Presence of the latent membrane protein 1 gene in nasopharyngeal swabs from patients with mucosal recurrent nasopharyngeal carcinoma. Cancer 2003;198:2385-2392.